- Product Details
Keywords
- 361442-04-8
- Saxagliptin 361442-04-8
- Saxagliptin 361442-04-8
Quick Details
- ProName: Saxagliptin 361442-04-8
- CasNo: 361442-04-8
- Molecular Formula: C18H25N3O2
- Appearance: White Solid
- Application: For Chemical Synthesis
- DeliveryTime: Prompt
- PackAge: In 25KG drums
- Port: Shanghai
- ProductionCapacity: 10 Metric Ton/Month
- Purity: 99.0%
- Storage: Room Temperature
- Transportation: As Per MSDS
- LimitNum: 1 Kilogram
- Moisture Content: N/A
- Impurity: N/A
- N/A: N/A
Superiority
Product Name: | Saxagliptin |
Synonyms: | Saxagliptin;(1S,3S,5S)-2-[(2S)-2-Amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile;BMS 477118;Onglyza;Saxagliptin(BMS 477118);Saxagliptin 15ND2;(1S,3S,5S)-2-[(2S)-2-aMino-2-(3-hydroxyadaMantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile;Saxagliptin HCl |
CAS: | 361442-04-8 |
MF: | C18H25N3O2 |
MW: | 315.414 |
EINECS: | |
Product Categories: | Amines;Chiral Reagents;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;organic pharmaceutical;Inhibitors |
Mol File: | 361442-04-8.mol |
Saxagliptin Chemical Properties |
density | 1.35 |
Details
Saxagliptin Basic information |
Product Name: | Saxagliptin |
Synonyms: | Saxagliptin;(1S,3S,5S)-2-[(2S)-2-Amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile;BMS 477118;Onglyza;Saxagliptin(BMS 477118);Saxagliptin 15ND2;(1S,3S,5S)-2-[(2S)-2-aMino-2-(3-hydroxyadaMantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile;Saxagliptin HCl |
CAS: | 361442-04-8 |
MF: | C18H25N3O2 |
MW: | 315.414 |
EINECS: | |
Product Categories: | Amines;Chiral Reagents;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;organic pharmaceutical;Inhibitors |
Mol File: | 361442-04-8.mol |
Saxagliptin Chemical Properties |
density | 1.35 |
Saxagliptin Usage And Synthesis |
Chemical Properties | White Solid |
Usage | Saxagliptin is a potent and selective reversible inhibitor of dipeptidyl peptidase-4, which is being developed for the treatment of type 2 diabetes. It is absorbed rapidly after oral administration an d has a pharmacokinetic profile compatible with once daily dosing. |